Clinical Investigator Career Development Award (CDA) supports early-career physician investigators leading lymphoma clinical studies to build research skills and advance lymphoma treatment.
Funder: Lymphoma Research Foundation
Due Dates (Anticipated): September 2027 (Full application)
Funding Amounts: $375,000 over three years ($125,000 per year)
Summary: Supports early-career physician investigators developing the skills to lead clinical research in lymphoma.
Key Information: Recipients must devote 35–50% of their time to research and cannot hold another career development award concurrently.
The Lymphoma Research Foundation’s Clinical Investigator Career Development Award supports advanced fellows and junior faculty preparing to design and administer clinical studies in lymphoma, including chronic lymphocytic leukemia (CLL). Its goal is to help physician investigators take primary responsibility for study design, protocol writing, Institutional Review Board submission, conduct, analysis, and publication.
Projects must center on hypothesis-driven clinical research involving human subjects. They may develop or assess therapies, diagnostic tools, or patient outcomes. Translational aims are permitted, but at least one clinical research aim must be the proposal’s primary focus; exclusively laboratory-based work is not appropriate. The Foundation’s Scientific Advisory Board reviews applications for their clinical research merit and potential impact on lymphoma treatment.